1. Home
  2. RGEN vs TXG Comparison

RGEN vs TXG Comparison

Compare RGEN & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Repligen Corporation

RGEN

Repligen Corporation

N/A

Current Price

$181.13

Market Cap

6.6B

Sector

Health Care

ML Signal

N/A

Logo 10x Genomics Inc.

TXG

10x Genomics Inc.

N/A

Current Price

$65.12

Market Cap

6.0B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
RGEN
TXG
Founded
1981
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Laboratory Analytical Instruments
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
6.6B
6.0B
IPO Year
1995
2019

Fundamental Metrics

Financial Performance
Metric
RGEN
TXG
Price
$181.13
$65.12
Analyst Decision
Buy
Hold
Analyst Count
12
15
Target Price
$167.67
$20.25
AVG Volume (30 Days)
1.2M
3.0M
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
286.96
76.97
EPS
0.24
N/A
Revenue
$141,236,000.00
$245,893,000.00
Revenue This Year
$14.30
N/A
Revenue Next Year
$14.52
$7.33
P/E Ratio
$751.21
N/A
Revenue Growth
35.10
68.06
52 Week Low
$100.99
$11.17
52 Week High
$188.73
$64.53

Technical Indicators

Market Signals
Indicator
RGEN
TXG
Relative Strength Index (RSI) 76.48 73.87
Support Level $156.65 $17.54
Resistance Level N/A N/A
Average True Range (ATR) 6.79 3.85
MACD 1.81 0.73
Stochastic Oscillator 84.69 98.84

Price Performance

Historical Comparison
RGEN
TXG

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

About TXG 10x Genomics Inc.

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).

Share on Social Networks: